前收市價 | 203.73 |
開市 | 203.98 |
買盤 | 0.00 x 1200 |
賣出價 | 240.00 x 900 |
今日波幅 | 194.90 - 204.80 |
52 週波幅 | 148.00 - 298.97 |
成交量 | |
平均成交量 | 458,438 |
市值 | 7.578B |
Beta 值 (5 年,每月) | 0.55 |
市盈率 (最近 12 個月) | 557.37 |
每股盈利 (最近 12 個月) | 0.35 |
業績公佈日 | 2024年10月31日 - 2024年11月04日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 201.33 |
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.
While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.